Thousands of melanoma patients in Europe have no access to new life saving drugs

Unacceptable inequalities in the availability and accessibility of new and effective cancer medications across Europe. Over 5000 patients with metastatic melanoma in Europe are denied access to new, life-saving drugs every year, according to a survey presented at the ESMO 2016 Congress in Copenhagen. Metastatic melanoma is an aggressive and deadly skin cancer. With innovative … Continue reading Thousands of melanoma patients in Europe have no access to new life saving drugs

Advertisements

Cancer treatment as a double-edged sword

Even with today's safer and more targeted anti-cancer drugs, scientists have been unable to satisfactorily explain the phenomenon of why treated cancers so often recur. The common theory is that the cancer cell develops "internal resistance to treatment," and overrides the toxic effects of the drug. Now, findings by a team of scientists led by … Continue reading Cancer treatment as a double-edged sword